Review
References
|
Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, Balasubramanyam A, Fatty Liver Subgroup of the Look AHEAD Research Group (2012). Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 56(3):952-960. |
|
|
Adams JM, Hart W, Gilmer DO, Lloyd-Richardson EE, Burton KA (2014). Concrete images of the sugar content in sugar-sweetened beverages reduces attraction to and selection of these beverages. Appetite 83:10-18. |
|
|
Alberti KGMM, Zimmet P, Shaw J (2006). Metabolic syndrome-a new world?wide definition. A consensus statement from the international diabetes federation. Diabetic Medicine 23(5):469-480. |
|
|
Alberti KGMM, Zimmet PZ (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 15(7):539-553. |
|
|
Agyemang-Yeboah F, Eghan BAJ, Annani-Akollor ME, Togbe E, Donkor S, Oppong AB (2019). Evaluation of metabolic syndrome and its associated risk factors in type 2 diabetes: A descriptive Cross?Sectional study at the komfo anokye teaching hospital, kumasi, Ghana. BioMed Research International 2019(1):4562904. |
|
|
Angelopoulos T, Lowndes J, Sinnett S, Rippe J. Fructose (2016). Containing Sugars at Normal Levels of Consumption Do Not Effect Adversely Components of the Metabolic Syndrome and Risk Factors for Cardiovascular Disease. Nutrients 23:8(4):179. |
|
|
Ayoub-Charette S, McGlynn ND, Lee D, Khan TA, Blanco Mejia S, Chiavaroli L, Kavanagh ME, Seider M, Taibi A, Chen CT, Ahmed A (2023). Rationale, design and participants baseline characteristics of a crossover randomized controlled trial of the effect of replacing SSBs with NSBs versus water on glucose tolerance, gut microbiome and Cardiometabolic risk in overweight or obese adult SSB consumer: strategies to oppose SUGARS with non-nutritive sweeteners or water (STOP sugars NOW) trial and ectopic fat sub-study. Nutrients 15(5):1238. |
|
|
Amouzegar A, Mehran L, Hasheminia M, Kheirkhah Rahimabad P, Azizi F (2017). The predictive value of metabolic syndrome for cardiovascular and all?cause mortality: Tehran Lipid and Glucose Study. Diabetes/Metabolism Research and Reviews 33(1):e2819. |
|
|
Ao H, Li J, Li O, Su M, Gao X (2020). Fructose vs glucose decreased liking/wanting and subsequent intake of high-energy foods in young women. Nutrition Research 78:60-71. |
|
|
Bordier V, Teysseire F, Schlotterbeck G, Senner F, Beglinger C, Meyer-Gerspach AC, Wölnerhanssen BK (2021). Effect of a chronic intake of the natural sweeteners xylitol and erythritol on glucose absorption in humans with obesity. Nutrients 13(11):3950. |
|
|
Burger KS (2017). Frontostriatal and behavioral adaptations to daily sugar-sweetened beverage intake: a randomized controlled trial1-3. The American Journal of Clinical Nutrition 105(3):555-63. |
|
|
Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, Keim NL (2012). Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women. European Journal of Clinical Nutrition 66(2):201-208. |
|
|
Choe EK, Rhee H, Lee S, Shin E, Oh SW, Lee JE, Choi SH (2018). Metabolic syndrome prediction using machine learning models with genetic and clinical information from a nonobese healthy population. Genomics and Informatics 16(4):e31. |
|
|
Canella DS, Levy RB, Martins APB, Claro RM, Moubarac JC, Baraldi LG, Monteiro CA (2014). Ultra-processed food products and obesity in Brazilian households (2008-2009). PloS one 9(3):e92752. |
|
|
Dearborn JL, Viscoli CM, Inzucchi SE, Young LH, Kernan WN (2019). Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease. International Journal of Stroke14(6):639-45. |
|
|
Domínguez-Coello S, Carrillo-Fernández L, Gobierno-Hernández J, Méndez-Abad M, Borges-Álamo C, García-Dopico JA, Aguirre-Jaime A, Cabrera-de León A (2020). Decreased consumption of added fructose reduces waist circumference and blood glucose concentration in patients with overweight and obesity. The DISFRUTE study: a randomised trial in primary care. Nutrients 12(4):1149. |
|
|
Ebbeling CB, Feldman HA, Chomitz VR, Antonelli TA, Gortmaker SL, Osganian SK, Ludwig DS (2012). A randomized trial of sugar-sweetened beverages and adolescent body weight. New England Journal of Medicine 367(15):1407-1416. |
|
|
Engel S, Tholstrup T, Bruun JM, Astrup A, Richelsen B, Raben A (2018). Effect of high milk and sugar-sweetened and non-caloric soft drink intake on insulin sensitivity after 6 months in overweight and obese adults: a randomized controlled trial. European Journal of Clinical Nutrition 72(3):358-366. |
|
|
Ferreira JP, Verma S, Fitchett D, Ofstad AP, Lauer S, Zwiener I, Inzucchi SE (2020). Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial. Cardiovascular Diabetology 19:1-9. |
|
|
Florez H, Temprosa MG, Orchard TJ, Mather KJ, Marcovina SM, Barrett?Connor E, Horton E, Saudek C, Pi?Sunyer XF, Ratner RE, Goldberg RB (2014). Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance. Diabetes, Obesity and Metabolism. 201416(4):326-33. |
|
|
Fortin A, Rabasa-Lhoret R, Lemieux S, Labonté ME, Gingras V (2018). Comparison of a Mediterranean to a low-fat diet intervention in adults with type 1 diabetes and metabolic syndrome: A 6-month randomized trial. Nutrition, Metabolism and Cardiovascular Diseases 28(12):1275-1284. |
|
|
GBD 2015 Obesity Collaborators (2017). Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine 377(1):13-27. |
|
|
Haufe S, Engeli S, Kast P, Böhnke J, Utz W, Haas V, Jordan J (2011). Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 53(5): 1504-1514. |
|
|
Hannou SA, Haslam DE, McKeown NM, Herman MA (2018). Fructose metabolism and metabolic disease. The Journal of Clinical Investigation 128(2):545-555. |
|
|
Haidari M, Leung N, Mahbub F, Uffelman KD, Kohen-Avramoglu R, Lewis GF, Adeli K (2002). Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance: evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. Journal of Biological Chemistry 277(35):31646-55. |
|
|
Hafezi SG, Mohammadi-Bajgiran M, Khorasanchi Z, Soflaei SS, Effati S, Rahimi HR, Shakeri B, Latifi M, Sarabi MM, Zadeh SG, Ghamsari M (2023). New dynamic approach models to estimate the effect of dietary fatty acids on lipid profiles and the incidence of cardiovascular disease in the MASHAD cohort study. |
|
|
Hernández-Ríos R, Hernández-Estrada S, Cruz-Robles D, Hernández-Lobato S, Villalobos-Martín M, Johnson RJ, Rodríguez-Castellanos F, Salazar J, García-Arroyo F, Sánchez-Lozada LG, Madero M (2013). Low fructose and low salt diets increase mitochondrial DNA in white blood cells of overweight subjects. Experimental and Clinical Endocrinology and Diabetes 121(09):535-538. |
|
|
Jang C, Hui S, Lu W, Cowan AJ, Morscher RJ, Lee G, Liu W, Tesz GJ, Birnbaum MJ, Rabinowitz JD (2018). The small intestine converts dietary fructose into glucose and organic acids. Cell metabolism 27(2):351-61. |
|
|
Johnston RD, Stephenson MC, Crossland H, Cordon SM, Palcidi E, Cox EF, Taylor MA, Aithal GP, Macdonald IA (2013). No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology 145(5):1016-25. |
|
|
Kim M, Astapova II, Flier SN, Hannou SA, Doridot L, Sargsyan A, Kou HH, Fowler AJ, Liang G, Herman MA (2017). Intestinal, but not hepatic, ChREBP is required for fructose tolerance. JCI Insight 2(24):e96703. |
|
|
Kim J, Mun S, Lee S, Jeong K, Baek Y (2022). Prediction of metabolic and pre-metabolic syndromes using machine learning models with anthropometric, lifestyle, and biochemical factors from a middle-aged population in Korea. BMC Public Health 22(1):664. |
|
|
Ko GTC, Cockram CS, Chow CC, Yeung V, Chan WB, So WY, Chan JCN (2005). High prevalence of metabolic syndrome in Hong Kong Chinese-comparison of three diagnostic criteria. Diabetes Research and Clinical Practice 69(2):160-168. |
|
|
Kirk E, Reeds DN, Finck BN, Mayurranjan SM, Patterson BW, Klein S (2009). Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 136(5):1552-60. |
|
|
Li XY, Li CP, Zhang CY, Zhang S, Chen JX, Zhu D, Chen FW, Wu ZZ, Hou DC, Zheng CY, Hou KJ (2022). Effect of polyethylene Glycol Loxenatide (long-acting GLP-1RA) on lipid, glucose levels and weight in type 2 diabetes mellitus patients with obesity. European Review for Medical and Pharmacological Sciences 26(21). |
|
|
Lecoultre V, Egli L, Carrel G, Theytaz F, Kreis R, Schneiter P, Tappy L (2013). Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. Obesity 21(4):782-785. |
|
|
Liao Y, Davies NA, Bogle IDL (2020). Computational modeling of fructose metabolism and development in NAFLD. Frontiers in Bioengineering and Biotechnology 8:762. |
|
|
Lin K, Zhang W, He F, Shen J (2022). Evaluation of the clinical efficacy of the treatment of overweight and obesity in type 2 diabetes mellitus by the telemedicine management system based on the internet of things technology. Computational Intelligence and Neuroscience 2022(1):8149515. |
|
|
Lowndes J, Sinnett S, Pardo S, Nguyen VT, Melanson KJ, Yu Z, Lowther BE, Rippe JM (2014). The effect of normally consumed amounts of sucrose or high fructose corn syrup on lipid profiles, body composition and related parameters in overweight/obese subjects. Nutrients 6(3):1128-1144. |
|
|
Mayfield K, Siskind D, Winckel K, Hollingworth S, Kisely S, Russell AW (2015). Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial. BJ Psych Open 1(1):67-73. |
|
|
Madero M, Arriaga JC, Jalal D, Rivard C, McFann K, Pérez-Méndez O, Lozada LGS (2011). The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial. Metabolism 60(11):1551-1559. |
|
|
Meshkani R, Adeli K (2009). Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clinical Biochemistry 42(13):1331-1346. |
|
|
Michael S, Lauer MD, Phil B, Fontanarosa MD (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III): Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults JAMA Network 285(19):2486-2497 |
|
|
Mortera RR, Bains Y, Gugliucci A (2019). Fructose at the crossroads of the metabolic syndrome and obesity epidemics. Frontiers in Bioscience-Landmark 24(2):186-211. |
|
|
Mohsenzadeh-Ledari F, Taghizadeh Z, Keramat A, Moosazadeh M, Yazdani S, Najafi A, Motaghi Z (2022). The effect of caring intervention (physical activity, diet and counseling) on gestational diabetes for pregnant women with metabolic syndrome. The Journal of Maternal-Fetal & Neonatal Medicine 35(21):4168-4174. |
|
|
Naguib MN, Hegedus E, Raymond JK, Goran MI, Salvy SJ, Wee CP, Durazo-Arvizu R, Moss L, Vidmar AP (2022). Continuous glucose monitoring in adolescents with obesity: monitoring of glucose profiles, glycemic excursions, and adherence to time restricted eating programs. Frontiers in Endocrinology 13:841838. |
|
|
Neeland IJ, Poirier P, Després JP (2018). Cardiovascular and Metabolic Heterogeneity of Obesity. Circulation 137(13):1391-406. |
|
|
Pasternak RC (2002). 2001 National Cholesterol Education Program (NCEP) Guidelines on the Detection, Evaluation and Treatment of Elevated Cholesterol in Adults: Adult Treatment Panel III (ATP III). ACC Current Journal Review 11(4):37-45. |
|
|
Patel C, Douard V, Yu S, Gao N, Ferraris RP (2015). Transport, metabolism, and endosomal trafficking-dependent regulation of intestinal fructose absorption. The FASEB Journal 29(9):4046-4058. |
|
|
Qiao Q, Gao W, Zhang L, Nyamdorj R, Tuomilehto J (2007). Metabolic syndrome and cardiovascular disease. Annals of Clinical Biochemistry 44(3):232-263. |
|
|
Reaven GM (2005). The insulin resistance syndrome: definition and dietary approaches to treatment. Annual Review of Nutrition 25:391-406. |
|
|
Rutledge AC, Adeli K (2007). Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutrition Reviews 65(suppl 1):S13-23. |
|
|
Sock ETN, Lê KA, Ith M, Kreis R, Boesch C, Tappy L (2010). Effects of a short-term overfeeding with fructose or glucose in healthy young males. British Journal of Nutrition 103(7):939-943. |
|
|
Sangüesa G, Shaligram S, Akther F, Roglans N, Laguna J C, Rahimian R, Alegret M (2017). Type of supplemented simple sugar, not merely calorie intake, determines adverse effects on metabolism and aortic function in female rats. American Journal of Physiology-Heart and Circulatory Physiology 312(2):H289-H304. |
|
|
Sari E, Yesilkaya E, Bolat A, Topal T, Altan B, Fidanci K, Güven A (2015). Metabolic and histopathological effects of fructose intake during pregestation, gestation and lactation in rats and their offspring. Journal of Clinical Research in Pediatric Endocrinology 7(1). |
|
|
Sevastianova K, Santos A, Kotronen A, Hakkarainen A, Makkonen J, Silander K, Yki-Järvinen H (2012). Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans123. The American Journal of Clinical Nutrition 96(4):727-734. |
|
|
Scott R, O'Brien R, Fulcher G, Pardy C, d'Emden M, Tse D, Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators (2009). Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetes Care 32(3):493-498. |
|
|
Schroder JD, Falqueto H, Mânica A, Zanini D, de Oliveira T, de Sá CA, Cardoso AM, Manfredi LH (2021). Effects of time-restricted feeding in weight loss, metabolic syndrome and cardiovascular risk in obese women. Journal of Translational Medicine19(1):3. |
|
|
Silbernagel G, Machann J, Unmuth S, Schick F, Stefan N, Häring HU, Fritsche A (2011). Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. British Journal of Nutrition 106(1):79-86. |
|
|
Softic S, Gupta MK, Wang GX, Fujisaka S, O'Neill BT, Rao TN, Willoughby J, Harbison C, Fitzgerald K, Ilkayeva O, Newgard CB (2017). Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. The Journal of clinical investigation 127(11):4059-4074. |
|
|
Softic S, Cohen DE, Kahn CR (2016). Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Digestive Diseases and Sciences 61:1282-93. |
|
|
Simmons D, Thompson CF (2004). Prevalence of the metabolic syndrome among adult New Zealanders of Polynesian and European descent. Diabetes Care 27(12):3002-3004. |
|
|
Sharma AK, Baig VN, Ahuja J, Sharma S, Panwar RB, Katoch VM, Gupta R (2021). Efficacy of IVRS-based mHealth intervention in reducing cardiovascular risk in metabolic syndrome: a cluster randomized trial. Diabetes & Metabolic Syndrome: Clinical Research and Reviews 15(5):102182. |
|
|
Stanhope KL (2016). Sugar consumption, metabolic disease and obesity: The state of the controversy. Critical reviews in clinical laboratory sciences 53(1):52-67. |
|
|
Stanhope KL (2012). Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome. Annual Review of Medicine 63(1):329-343. |
|
|
Stanhope KL, Havel PJ (2010). Fructose consumption: recent results and their potential implications. Annals of the New York Academy of Sciences 1190(1):15-24. |
|
|
Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Havel PJ (2009). Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. The Journal of Clinical Investigation 119(5):1322-1334. |
|
|
Sun SZ, Empie MW (2012). Fructose metabolism in humans-what isotopic tracer studies tell us. Nutrition and Metabolism 9:1-15. |
|
|
Tappy L (2018). Fructose-containing caloric sweeteners as a cause of obesity and metabolic disorders. Journal of Experimental Biology 221(Suppl_1): jeb164202. |
|
|
Tappy L, Lê KA (2010). Metabolic effects of fructose and the worldwide increase in obesity. Physiological Reviews 90(1):23-46. |
|
|
Taskinen MR, Söderlund S, Bogl LH, Hakkarainen A, Matikainen N, Pietiläinen KH, Borén J (2017). Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity. Journal of Internal Medicine 282(2):187-201. |
|
|
Tay J, Thompson CH, Luscombe?Marsh ND, Wycherley TP, Noakes M, Buckley JD, Wittert GA, Yancy Jr WS, Brinkworth GD (2018). Effects of an energy?restricted low?carbohydrate, high unsaturated fat/low saturated fat diet versus a high?carbohydrate, low?fat diet in type 2 diabetes: a 2?year randomized clinical trial. Diabetes, Obesity and Metabolism 20(4):858-71. |
|
|
Van Ruiten CC, Veltman DJ, Schrantee A, Van Bloemendaal L, Barkhof F, Kramer MH, Nieuwdorp M, IJzerman RG (2022). Effects of dapagliflozin and combination therapy with exenatide on food-cue induced brain activation in patients with type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism 107(6):e2590-2599. |
|
|
Weinstock RS, Drews KL, Caprio S, Leibel NI, McKay SV, Zeitler PS (2015). Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: Results from the TODAY clinical trial. Obesity 23(7):1357-61. |
|
|
Wilkinson MJ, Manoogian EN, Zadourian A, Lo H, Fakhouri S, Shoghi A, Wang X, Fleischer JG, Navlakha S, Panda S, Taub PR. (2020) Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metabolism 7:31(1):92-104. |
|
|
Woyesa SB, Hirigo AT, Wube TB (2017). Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia. BMC Endocrine Disorders 17:1-8. |
|
|
Xiao C, Dash S, Morgantini C, Lewis GF (2013). Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans. Arteriosclerosis, Thrombosis, and Vascular Biology 33(5):1056-62. |
|
|
Yang H, Yu B, OU Yang P, Li X, Lai X, Zhang G, Zhang H (2022). Machine learning-aided risk prediction for metabolic syndrome based on 3 years study. Scientific Reports 12(1):2248. |
|
|
Yun JE, Won S, Sung J, Jee SH (2012). Impact of metabolic syndrome independent of insulin resistance on the development of cardiovascular disease. Circulation Journal 76(10):2443-2448. |
|
|
Yunker AG, Alves JM, Luo S, Angelo B, DeFendis A, Pickering TA, Monterosso JR, Page KA (2021). Obesity and sex-related associations with differential effects of sucralose vs sucrose on appetite and reward processing: a randomized crossover trial. JAMA Network Open 4(9):e2126313. |
|
|
Zhang H, Chen D, Shao J, Zou P, Cui N, Tang L, Ye Z (2021). Machine learning-based prediction for 4-year risk of metabolic syndrome in adults: a retrospective cohort study. Risk Management and Healthcare Policy 4361-4368. |
|
|
Zheng X, Yu H, Qiu X, Chair SY, Wong EM, Wang Q (2020). The effects of a nurse-led lifestyle intervention program on cardiovascular risk, self-efficacy and health promoting behaviours among patients with metabolic syndrome: randomized controlled trial. International Journal of Nursing Studies 109:103638. |
|
|
Zhu H, Chen X, Zhang B, Yang W, Xing X (2021). Family history of diabetes and the effectiveness of lifestyle intervention on insulin secretion and insulin resistance in Chinese individuals with metabolic syndrome. Journal of Diabetes Research 2021(1):8822702. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
